A detailed history of Vantage Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vantage Investment Partners, LLC holds 16,378 shares of LLY stock, worth $12.3 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
16,378
Previous 17,981 8.91%
Holding current value
$12.3 Million
Previous $16.3 Million 10.87%
% of portfolio
1.22%
Previous 1.48%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $1.24 Million - $1.54 Million
-1,603 Reduced 8.91%
16,378 $14.5 Million
Q2 2024

Jul 29, 2024

SELL
$724.87 - $909.04 $1.82 Million - $2.28 Million
-2,505 Reduced 12.23%
17,981 $16.3 Million
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $5.46 Million - $7.31 Million
-9,227 Reduced 31.05%
20,486 $15.9 Million
Q4 2023

Jan 31, 2024

SELL
$525.19 - $619.13 $735,791 - $867,401
-1,401 Reduced 4.5%
29,713 $17.3 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $285,163 - $393,140
656 Added 2.15%
31,114 $16.7 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $4.01 Million - $5.36 Million
-11,427 Reduced 27.28%
30,458 $14.3 Million
Q1 2023

Apr 18, 2023

BUY
$310.63 - $364.82 $157,800 - $185,328
508 Added 1.23%
41,885 $14.4 Million
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $100,323 - $116,897
312 Added 0.76%
41,377 $15.1 Million
Q3 2022

Oct 18, 2022

BUY
$296.48 - $337.87 $33,205 - $37,841
112 Added 0.27%
41,065 $13.3 Million
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $1.49 Million - $1.75 Million
-5,341 Reduced 11.54%
40,953 $13.3 Million
Q1 2022

Apr 22, 2022

BUY
$234.69 - $291.66 $93,171 - $115,789
397 Added 0.86%
46,294 $13.3 Million
Q4 2021

Jan 21, 2022

BUY
$224.85 - $279.04 $936,275 - $1.16 Million
4,164 Added 9.98%
45,897 $12.7 Million
Q3 2021

Oct 13, 2021

SELL
$221.6 - $272.71 $3.71 Million - $4.57 Million
-16,754 Reduced 28.65%
41,733 $9.64 Million
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $2.32 Million - $3 Million
12,865 Added 28.2%
58,487 $13.4 Million
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $4.72 Million - $6.11 Million
-28,716 Reduced 38.63%
45,622 $8.52 Million
Q4 2020

Jan 25, 2021

SELL
$130.46 - $172.63 $2.4 Million - $3.17 Million
-18,377 Reduced 19.82%
74,338 $12.6 Million
Q3 2020

Oct 22, 2020

BUY
$146.22 - $169.13 $342,154 - $395,764
2,340 Added 2.59%
92,715 $13.7 Million
Q2 2020

Jul 21, 2020

BUY
$136.42 - $164.18 $415,398 - $499,928
3,045 Added 3.49%
90,375 $14.8 Million
Q1 2020

Apr 28, 2020

BUY
$119.05 - $147.35 $183,813 - $227,508
1,544 Added 1.8%
87,330 $12.1 Million
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $13,899 - $17,215
130 Added 0.15%
85,786 $11.3 Million
Q3 2019

Oct 24, 2019

BUY
$106.79 - $116.16 $1,495 - $1,626
14 Added 0.02%
85,656 $9.58 Million
Q2 2019

Aug 07, 2019

SELL
$110.79 - $129.32 $1.78 Million - $2.07 Million
-16,034 Reduced 15.77%
85,642 $9.49 Million
Q1 2019

May 10, 2019

BUY
$111.31 - $131.02 $2,114 - $2,489
19 Added 0.02%
101,676 $13.2 Million
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $158,320 - $177,366
-1,495 Reduced 1.45%
101,657 $11.8 Million
Q3 2018

Oct 31, 2018

SELL
$85.86 - $107.31 $516,533 - $645,576
-6,016 Reduced 5.51%
103,152 $11.1 Million
Q2 2018

Aug 01, 2018

SELL
$75.7 - $86.88 $2.55 Million - $2.92 Million
-33,621 Reduced 23.55%
109,168 $9.31 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $1.45 Million - $1.71 Million
19,513 Added 15.83%
142,789 $11 Million
Q4 2017

Feb 15, 2018

BUY
$81.94 - $87.89 $9.09 Million - $9.75 Million
110,949 Added 900.05%
123,276 $10.4 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $10.8 Million - $11.6 Million
-131,943 Reduced 91.46%
12,327 $1.04 Million
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $345,196 - $383,133
-4,479 Reduced 3.01%
144,270 $12.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
148,749
148,749 $12.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vantage Investment Partners, LLC Portfolio

Follow Vantage Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Investment Partners, LLC with notifications on news.